SDHA c.632A>G ;(p.Y211C)
Variant ID: 5-228310-A-G
NM_004168.2(SDHA):c.632A>G;(p.Y211C)
This variant was identified in 2 publications
Variant-Specific Resource Links:
Publications:
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
Ebiomedicine
Shi, Yuankai Y; Su, Hang H; Song, Yongping Y; Jiang, Wenqi W; Sun, Xiuhua X; Qian, Wenbin W; Zhang, Wei W; Gao, Yuhuan Y; Jin, Zhengming Z; Zhou, Jianfeng J; Jin, Chuan C; Zou, Liqun L; Qiu, Lugui L; Li, Wei W; Yang, Jianmin J; Hou, Ming M; Xiong, Yan Y; Zhou, Hui H; Du, Xinhua X; Wang, Xiong X; Peng, Bo B
Publication Date: 2020-04
Variant appearance in text: SDHA: 632A>G; Y211C
Variant Present in the following documents:
The emerging role and targetability of the TCA cycle in cancer metabolism.
Protein & Cell
Anderson, Nicole M NM; Mucka, Patrick P; Kern, Joseph G JG; Feng, Hui H
Publication Date: 2018-02
Variant appearance in text: SDHA: 632A>G
Variant Present in the following documents:
- Main text
- 13238_2017_Article_451.pdf